Brokerages Set ReWalk Robotics Ltd (RWLK) PT at $5.40

Shares of ReWalk Robotics Ltd (NASDAQ:RWLK) have been assigned a consensus rating of “Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and five have given a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $5.40.

RWLK has been the subject of a number of research analyst reports. Barclays PLC lowered shares of ReWalk Robotics from an “equal weight” rating to an “underweight” rating and reduced their target price for the stock from $2.50 to $1.50 in a research note on Monday, April 3rd. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $4.00 target price (down from $7.00) on shares of ReWalk Robotics in a research note on Wednesday, May 10th. Zacks Investment Research raised shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 target price for the company in a research note on Thursday, May 11th. Finally, Canaccord Genuity reaffirmed a “buy” rating on shares of ReWalk Robotics in a research note on Monday, June 12th.

A number of institutional investors have recently made changes to their positions in RWLK. Renaissance Technologies LLC boosted its stake in shares of ReWalk Robotics by 171.5% in the fourth quarter. Renaissance Technologies LLC now owns 48,600 shares of the medical device company’s stock valued at $136,000 after buying an additional 30,700 shares during the period. Menta Capital LLC boosted its stake in shares of ReWalk Robotics by 17.4% in the fourth quarter. Menta Capital LLC now owns 49,304 shares of the medical device company’s stock valued at $138,000 after buying an additional 7,306 shares during the period. WFG Advisors LP boosted its stake in shares of ReWalk Robotics by 4,004.9% in the fourth quarter. WFG Advisors LP now owns 164,194 shares of the medical device company’s stock valued at $2,312,000 after buying an additional 160,194 shares during the period. Finally, Highbridge Capital Management LLC acquired a new stake in shares of ReWalk Robotics during the fourth quarter valued at approximately $1,400,000. 4.45% of the stock is owned by hedge funds and other institutional investors.

Shares of ReWalk Robotics (NASDAQ RWLK) remained flat at $1.80 during mid-day trading on Monday. The company’s stock had a trading volume of 328,746 shares. The firm’s market capitalization is $30.02 million. ReWalk Robotics has a 52-week low of $1.10 and a 52-week high of $7.85. The firm has a 50 day moving average price of $1.26 and a 200-day moving average price of $2.03.

ReWalk Robotics (NASDAQ:RWLK) last announced its earnings results on Thursday, May 4th. The medical device company reported ($0.33) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.43) by $0.10. The firm had revenue of $2.50 million during the quarter, compared to analyst estimates of $2.45 million. ReWalk Robotics had a negative net margin of 507.07% and a negative return on equity of 496.02%. The company’s revenue for the quarter was up 21.3% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.48) EPS. Equities analysts forecast that ReWalk Robotics will post ($1.44) EPS for the current year.

TRADEMARK VIOLATION WARNING: “Brokerages Set ReWalk Robotics Ltd (RWLK) PT at $5.40” was reported by sleekmoney and is the property of of sleekmoney. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://sleekmoney.com/brokerages-set-rewalk-robotics-ltd-rwlk-pt-at-5-40/1932768.html.

About ReWalk Robotics

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/brokerages-set-rewalk-robotics-ltd-rwlk-pt-at-5-40/1932768.html

Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *